7.100
−5,33%
2026-10-19
Fundamental Analysis
70 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +199.8% | +37.7% | 2 / 3 | +73.0% | +2.21 pp | +13.57 pp | +6.7% | 0.65 | 13.16 | 308 | +73,0% | 2,8 | +112,5% | 13.16 | 10.61 | +24,1% |
| Pts | 12 | 8 | 8 | 12 | 8 | 12 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 7.100 (close price on 2026-10-19)EPS (TTM): 539,4
Financial charts
1.Revenue & growth
VND bn308Q2/26
1.Revenue & growth
VND bn308Q2/26
2.Profit & growth
VND bn13,7Q2/26
3.Profit mix (Penman)
VND bn178Q2/26
4.Margins & cost structure
%48.1%Q2/26
5.Returns & cash cycle
% · days6.0%Q2/26
6.Earnings quality & cash
VND bn201Q2/26
7.Asset structure
VND bn3.787Q2/26
8.Funding & debt health
VND bn · times3.787Q2/26
9.Revenue backlog
VND bn10,6Q2/26
10.Valuation
times · %13,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %69Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
-115%
averaged over 1 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26